David Goodall ends his life in Basel assisted suicide
The 104-year-old Australian scientist who drew international attention this week to his right-to-die campaign ended his life on Thursday, advocacy group Exit International has said.
“At 12.30 today (10th May) Professor David Goodall, 104 years of age, died peacefully at Life Cycle, Basel, Switzerland from an infusion of Nembutal,” Exit International founder Philip Nitschke tweeted shortly after Goodall’s passing.
Goodall was not suffering from any terminal diseases, but had decided that his deteriorating quality of life meant that it was time to go.
At a press conference in Basel on Wednesday, he told reporters that he was happy to have the chance to end his life in Switzerland but would have preferred to do so back home.
More
More
Australian scientist’s final words in Switzerland
This content was published on
A 104-year-old Australian scientist who ended his life in Switzerland on Thursday explained on the eve of his assisted suicide why choosing how and when to die should be a right.
“Everyone over middle age should have the right unquestioned to end their lives as and when they choose, but we have quite a way to go in Australia for that,” he said.
Switzerland is one of the few countries in the world to allow assisted suicide, and hundreds come to the country every year to do so with groups such as Dignitas and Life Circle, Goodall’s choice.
The Associated Press quoted Exit International’s Nitschke, who was present at Goodall’s side, saying that the British-born Australian answered, “with great clarity”, the control questions to ensure patients are aware of who they are, where they are, and what they are about to do.
He requested that no funeral or remembrance service be held and that his body be donated to medicine or his ashes sprinkled locally.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.